Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Inv. presentation Quarterly results Appointed director
|
ADIAL PHARMACEUTICALS, INC. (ADIL)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/03/2023 |
4
| Schuyler Kevin (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Bought 700 shares
@ $2.74, valued at
$1.9k
|
|
06/02/2023 |
4
| Johnson Bankole A. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 40,000 options
@ $0.3025, valued at
$12.1k
|
|
05/25/2023 |
4
| Truluck Joseph (CFO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 157,500 shares
@ $0 Granted 125,000 options to buy
@ $0.3025, valued at
$37.8k
|
|
05/25/2023 |
4
| Stilley William B. III (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 240,800 shares
@ $0 Granted 50,000 options to buy
@ $0.3025, valued at
$15.1k
|
|
05/25/2023 |
4
| Schuyler Kevin (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 50,000 options to buy
@ $0.3025, valued at
$15.1k
|
|
05/25/2023 |
4
| Newman James W. Jr. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 50,000 options to buy
@ $0.3025, valued at
$15.1k
|
|
05/25/2023 |
4
| Goodman Tony (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 50,000 options to buy
@ $0.3025, valued at
$15.1k
|
|
05/25/2023 |
4
| Gilliland Robertson H. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 50,000 options to buy
@ $0.3025, valued at
$15.1k
|
|
05/25/2023 |
4
| Claiborne Cary J (CEO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 420,000 shares
@ $0 Granted 300,000 options to buy
@ $0.3025, valued at
$90.8k
|
|
05/25/2023 |
4
| Anderson J. Kermit (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 50,000 options to buy
@ $0.3025, valued at
$15.1k
|
|
01/03/2023 |
4
| Stilley William B. III (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Disposed/sold 166,667 shares
@ $0 |
|
09/20/2022 |
4
| Claiborne Cary J (CEO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 25,000 shares
@ $0.4294, valued at
$10.7k
Granted 75,000 shares
@ $0.4202, valued at
$31.5k
|
|
08/23/2022 |
4
| Stilley William B. III (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 100,000 options
@ $0.555, valued at
$55.5k
|
|
08/22/2022 |
4
| Claiborne Cary J (CEO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 1,000,000 shares
@ $0 |
|
06/28/2022 |
4
| Goodman Tony (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 25,000 options
@ $1.23, valued at
$30.8k
|
|
02/25/2022 |
4
| Johnson Bankole A. (Chief Medical Officer) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 35,000 options to buy
@ $2, valued at
$70k
|
|
02/25/2022 |
4
| Goodman Tony (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 40,000 options
@ $2, valued at
$80k
|
|
02/25/2022 |
4
| Truluck Joseph (CFO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 100,000 options to buy
@ $2, valued at
$200k
|
|
02/25/2022 |
4
| Stilley William B. III (CEO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 250,000 shares
@ $0 |
|
02/25/2022 |
4
| Schuyler Kevin (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 40,000 options
@ $2, valued at
$80k
|
|
02/25/2022 |
4
| Newman James W. Jr. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 40,000 options
@ $2, valued at
$80k
|
|
02/25/2022 |
4
| Gilliland Robertson H. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 40,000 options
@ $2, valued at
$80k
|
|
02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/25/2022 |
4
| Anderson J. Kermit (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 40,000 options
@ $2, valued at
$80k
|
|
01/03/2022 |
4
| Newman James W. Jr. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Bought 10,000 shares
@ $2.66, valued at
$26.6k
Bought 5,000 shares
@ $2.72, valued at
$13.6k
Bought 10,000 shares
@ $2.71, valued at
$27.1k
|
|
12/23/2021 |
4
| Schuyler Kevin (10% Owner) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Gifted 312,990 shares
@ $0 Gifted 90,000 options to buy
@ $6.25, valued at
$562.5k
|
|
12/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/01/2021 |
4
| Stilley William B. III (CEO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Bought 10,000 shares
@ $2.5892, valued at
$25.9k
Bought 10,600 shares
@ $2.7527, valued at
$29.2k
|
|
11/30/2021 |
4
| Newman James W. Jr. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Bought 10,000 shares
@ $2.85, valued at
$28.5k
|
|
11/03/2021 |
4
| Claiborne Cary J (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 60,000 options
@ $3.15, valued at
$189k
|
|
10/06/2021 |
4
| Johnson Bankole A. (Chief Medical Officer) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Sold 200,000 shares
@ $0 Disposed of 150,000 warrants
@ $0 |
|
04/08/2021 |
4
| Johnson Bankole A. (Chief Medical Officer) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Sold 150,000 shares
@ $2.5, valued at
$375k
|
|
02/10/2021 |
4
| Truluck Joseph (CFO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns:
| Granted 125,000 options to buy
@ $3.11, valued at
$388.8k
|
|
02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|